imatinib (AER-901) - Aerami Therap
Blincyto (blinatumomab) - Astellas, Amgen
tuspetinib (HM43239) - Aptose Biosci
Venclexta (venetoclax) - Roche, AbbVie, Walter and Eliza Hall Institute
Xospata (gilteritinib) - Astellas
Tibsovo (ivosidenib) - Servier
Iclusig (ponatinib) - Takeda, Otsuka, Incyte
magrolimab (GS-4721) - Ono Pharma, Gilead
Idhifa (enasidenib) - BMS, Servier
https://www.onclive.com/view/rapid-advances-shake-up-treatment-considerations-in-all-cml-aml
 
Apr 6, 2023
 
Prev Next